Dementia with Lewy bodies risk down with α-1 adrenergic receptor antagonists
Jun 19, 2024
The risk for developing dementia with Lewy bodies was lower for men newly started on Tz/Dz/Az compared with those taking tamsulosin or 5ARI.
American Academy of Neurology, April 13-18
Apr 23, 2024
The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians, academicians, allied health professionals,...
Eligibility limited for anti-β amyloid mAbs in seniors with MCI
Aug 18, 2023
Few older adults with mild cognitive impairment or mild dementia were eligible for lecanemab or aducanumab after applying clinical trial criteria.
Minorities with dementia show lower incidence of amyloid PET positivity
Oct 12, 2022
The authors say that the findings have implications for treating dementia unrelated to amyloid plaques.
Seizures in young stroke survivors double dementia risk
Jul 29, 2022
The findings were seen for all strokes, ischemic strokes and hemorrhagic strokes.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
Higher habitual coffee intake may slow cognitive decline
Nov 30, 2021
Higher baseline coffee consumption also was linked to slower Aβ-amyloid accumulation during a 126-month study period, as shown on brain MRI scans.
Migraine linked to all-cause dementia, Alzheimer’s disease
Oct 07, 2021
No association was observed between migraine and a risk for vascular dementia in meta-analysis of five cohort studies.